Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 11:22:16 - browse：117

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Illumina names Agilent executive as new CEO

entertainment

WSS

HCA says smaller share of spending going to labor

What American doctors can learn from their Israeli counterparts

NIH nominee Bertagnolli will get October confirmation hearing

What AstraZeneca

NIH nominee Bertagnolli will get October confirmation hearing

'Make People Better': The CRISPR babies story you probably don't know

Wikipedia

Wikipedia

hotspot

Apple is now the first public company to be valued at $3 trillion

Many immigrants are left out of maternal health programs

The cancer drug shortage isn’t new — and neither are the solutions

Trump surgeon general acknowledges mistakes during Covid

Affirmative action in medical school literally saved lives

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Peter Hotez and the public health issue of online harassment

Russian and Belarusian players banned from a women's tennis tournament in Prague

Peter Hotez and the public health issue of online harassment

A rare thyroid diagnosis led to unexpected, all

hotspot

A rare thyroid diagnosis led to unexpected, all

The (many) problems with a new study criticizing cancer screening

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

Covid hospitalizations on the rise, Humana says

Weighted lottery helped low

entertainment

knowledge

leisure time

hotspot